Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2003 1
2004 2
2005 2
2006 1
2007 2
2008 4
2009 9
2010 7
2011 5
2012 4
2013 3
2014 3
2015 3
2016 6
2017 5
2018 9
2019 5
2020 1
2021 2
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes.
Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group. Ninomiya T, et al. J Am Soc Nephrol. 2009 Aug;20(8):1813-21. doi: 10.1681/ASN.2008121270. Epub 2009 May 14. J Am Soc Nephrol. 2009. PMID: 19443635 Free PMC article.
There are limited data regarding whether albuminuria and reduced estimated GFR (eGFR) are separate and independent risk factors for cardiovascular and renal events among individuals with type 2 diabetes. The Action in Diabetes and Vascular disease: preterAx and diamicroN- …
There are limited data regarding whether albuminuria and reduced estimated GFR (eGFR) are separate and independent risk factors for cardiova …
What matters in ADVANCE and ADVANCE-ON.
Hamet P. Hamet P. Diabetes Obes Metab. 2012 Jan;14 Suppl 1:20-9. doi: 10.1111/j.1463-1326.2011.01509.x. Diabetes Obes Metab. 2012. PMID: 22118707 Review.
Evidence for combined approaches in controlling for BP and blood glucose was provided by Action in Diabetes and Vascular disease: PreterAx and DiamicroN-MR Controlled Evaluation (ADVANCE), conducted in over 11 000 subjects from 20 countries. ...
Evidence for combined approaches in controlling for BP and blood glucose was provided by Action in Diabetes and Vascular disease: PreterAx a …
New insights from ADVANCE.
Chalmers J, Kengne AP, Joshi R, Perkovic V, Patel A. Chalmers J, et al. J Hypertens Suppl. 2007 Jun;25(1):S23-30. doi: 10.1097/01.hjh.0000271506.69949.46. J Hypertens Suppl. 2007. PMID: 17579315 Review.
OBJECTIVES: ADVANCE (Action in Diabetes and Vascular Disease - PreterAx and DiamicroN MR Controlled Evaluation) is a large-scale clinical trial designed to investigate the benefits of blood pressure lowering and intensive glucose control in patients with type 2 diab …
OBJECTIVES: ADVANCE (Action in Diabetes and Vascular Disease - PreterAx and DiamicroN MR Controlled Evaluation) is a large-sca …
The kidney and cardiovascular outcome trials.
Bloomgarden Z. Bloomgarden Z. J Diabetes. 2018 Feb;10(2):88-89. doi: 10.1111/1753-0407.12616. J Diabetes. 2018. PMID: 29031006
Improvement in albuminuria has been shown in clinical trials of glycemic interventions, including the Action to Control Cardiovascular Disease in Diabetes (ACCORD) trial, the Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation (A …
Improvement in albuminuria has been shown in clinical trials of glycemic interventions, including the Action to Control Cardiovascular Disea …
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes.
Wang N, Harris K, Hamet P, Harrap S, Mancia G, Poulter N, Williams B, Zoungas S, Woodward M, Chalmers J, Rodgers A. Wang N, et al. J Am Coll Cardiol. 2022 Sep 20;80(12):1147-1155. doi: 10.1016/j.jacc.2022.06.039. J Am Coll Cardiol. 2022. PMID: 36109108 Free article.
These findings reinforce the importance of both the magnitude and duration of exposure to elevated SBP in assessing cardiovascular risk. (Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study [ADVANCE- …
These findings reinforce the importance of both the magnitude and duration of exposure to elevated SBP in assessing cardiovascular risk. (Ac …
Target blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?
Nilsson PM. Nilsson PM. J Zhejiang Univ Sci B. 2011 Aug;12(8):611-23. doi: 10.1631/jzus.B1101001. J Zhejiang Univ Sci B. 2011. PMID: 21796800 Free PMC article. Review.
Based on evidence from both randomized controlled trials (hypertension optimal treatment (HOT), action in diabetes and vascular disease: preterax and diamicron MR controlled evaluation (ADVANCE), action to control cardiovascular risk in diabetes (ACCORD)) and observ …
Based on evidence from both randomized controlled trials (hypertension optimal treatment (HOT), action in diabetes and vascular disease: pre …
RAS inhibitors' dose-dependent efficacy: myth or reality?
Taddei S. Taddei S. Curr Med Res Opin. 2015;31(7):1245-56. doi: 10.1185/03007995.2015.1053047. Epub 2015 Jun 9. Curr Med Res Opin. 2015. PMID: 25985327 Review.
Furthermore, for all-cause mortality, ACE inhibitors have been shown to be better than ARBs, a specific efficacy supported by perindopril-based studies including ASCOT-BPLA (the Anglo-Scandinavian Cardiac Outcomes Trial-BP Lowering Arm), ADVANCE (the Action in Diabetes and Vascul …
Furthermore, for all-cause mortality, ACE inhibitors have been shown to be better than ARBs, a specific efficacy supported by perindopril-ba …
Validation and comparison of cardiovascular risk prediction equations in Chinese patients with Type 2 diabetes.
Liang J, Li Q, Fu Z, Liu X, Shen P, Sun Y, Zhang J, Lu P, Lin H, Tang X, Gao P. Liang J, et al. Eur J Prev Cardiol. 2023 Sep 6;30(12):1293-1303. doi: 10.1093/eurjpc/zwad198. Eur J Prev Cardiol. 2023. PMID: 37315163
Five-year CVD risk was calculated using original and recalibrated diabetes-specific models [Action in Diabetes and Vascular disease: PreterAx and diamicroN-MR Controlled Evaluation (ADVANCE) and the Hong Kong cardiovascular risk model (HK)] and general population-ba …
Five-year CVD risk was calculated using original and recalibrated diabetes-specific models [Action in Diabetes and Vascular disease: PreterA …
74 results